查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1819933

2025-2033年呼吸道合胞病毒診斷市場報告（依產品、最終用途及地區）

Respiratory Syncytial Virus Diagnostics Market Report by Product, End Use, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球呼吸道合胞病毒 (RSV) 診斷市場規模達 10.87 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 21.52 億美元，2025-2033 年期間的成長率 (CAGR) 為 7.9%。

呼吸道合胞病毒 (RSV) 是一種肺部和呼吸道病毒感染，可導致氣喘、住院、肺炎、反覆感染、中耳炎甚至死亡。此病可透過血液檢查、胸部 X 光檢查、分泌物拭子採集和脈搏血氧飽和度測定等方法進行診斷，檢查內容包括肺部發炎、白血球 (WBC) 計數和血氧水平。 RSV 的一些常用治療方法包括非處方藥 (OTC)、靜脈輸液 (IV)、濕化氧氣、機械通氣和吸入性支氣管擴張劑。

呼吸道合胞病毒（RSV）診斷市場趨勢：

由於兩歲以下兒童容易出現嚴重的呼吸道症狀，新生兒呼吸道合胞病毒（RSV）感染的嚴重程度可能較高。這與家長對兒童醫療保健的日益關注相結合，是促進市場成長的關鍵因素之一。此外，早期診斷的高存活率和便捷的診斷方法也是促進市場成長的其他因素。此外，醫療基礎設施的改善和住院嬰兒治療的優惠報銷政策也促進了市場的成長。此外，生物技術和奈米技術等先進技術的出現，促進了現代RSV檢測系統的開發，例如蛋白質印跡法、酶聯免疫吸附試驗（ELISA）、直接免疫螢光法和即時聚合酶鍊式反應（PCR）。此外，許多國家的管理機構正在資助用於開發新療法的研發計畫。預計推動市場發展的其他因素包括臨床疫苗試驗數量的增加、體外診斷需求的不斷成長、兒童肺炎發病率的上升以及分子診斷的日益普及。

本報告回答的關鍵問題：

  • 全球呼吸道合胞病毒 (RSV) 診斷市場迄今表現如何，未來幾年將如何表現？
  • COVID-19 對全球呼吸道合胞病毒 (RSV) 診斷市場有何影響？
  • 主要的區域市場有哪些？
  • 根據產品，市場是如何分類的？
  • 根據最終用途，市場是如何分類的？
  • 該產業的價值鏈分為哪些階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球呼吸道合胞病毒 (RSV) 診斷市場的結構是如何的？主要參與者是誰？
  • 產業競爭程度如何？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球呼吸道合胞病毒（RSV）診斷市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 直接螢光抗體（DFA）法
  • 快速抗原診斷測試（RADT）
  • 分子診斷
  • 色譜免疫分析法
  • 診斷影像
  • 凝膠微滴
  • 流式細胞儀
  • 其他

第 7 章：市場區隔：最終用途別

  • 醫院和診所
  • 實驗室
  • 其他

第8章：市場區隔：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章：SWOT分析

第 10 章：價值鏈分析

第 11 章：波特五力分析

第 12 章：價格分析

第 13 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Coris BioConcept
    • DiaSorin Molecular LLC (DiaSorin Inc)
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Quest Diagnostics Incorporated
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A4048

The global respiratory syncytial virus (RSV) diagnostics market size reached USD 1,087.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,152.0 Million by 2033, exhibiting a growth rate (CAGR) of 7.9% during 2025-2033.

Respiratory syncytial virus (RSV) is a viral infection of the lungs and respiratory tract, which can cause asthma, hospitalization, pneumonia, repeated infections, middle ear infection, and death. It can be diagnosed using blood tests, chest x-rays, a swab of secretions, and pulse oximetry by checking for signs like lung inflammation, white blood cell (WBC) count, and oxygen levels in the blood. Some of the commonly available treatment options for RSV are over-the-counter (OTC) medications, intravenous (IV) fluids, humidified oxygen, mechanical ventilation, and inhaled bronchodilators.

Respiratory Syncytial Virus (RSV) Diagnostics Market Trends:

RSV infection can be more serious during the neonatal period as children under two years of age tend to develop severe respiratory symptoms. This, in confluence with the rising focus of parents on child medical care, represents one of the crucial factors fostering the growth of the market. Moreover, the high survival rates after early diagnosis and the easy availability of diagnostic modalities act as other growth-inducing factors. Apart from this, the improving healthcare infrastructure and favorable reimbursement policies for the treatment of hospitalized infants are also contributing to market growth. Furthermore, the advent of advanced techniques like bio- and nanotechnology is facilitating the development of modern detection systems for RSV, such as western blot, enzyme-linked immunosorbent assay (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR). Besides this, governing agencies of numerous countries are funding research and development (R&D) projects for the development of new therapeutics. Other factors projected to drive the market are the growing number of clinical vaccine trials, the escalating demand for in-vitro diagnostics, rising incidences of childhood pneumonia and the increasing adoption of molecular diagnostics.

Key Market Segmentation:

Breakup by Product:

  • Direct Fluorescent Antibody (DFA) Method
  • Rapid Antigen Diagnostic Test (RADTs)
  • Molecular Diagnostics
  • Chromatographic Immunoassay
  • Diagnostic Imaging
  • Gel Microdroplets
  • Flow Cytometry
  • Others

Breakup by End Use:

  • Hospitals and Clinics
  • Laboratory
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Coris BioConcept, DiaSorin Molecular LLC (DiaSorin Inc), F. Hoffmann-La Roche AG, Merck KGaA, Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global respiratory syncytial virus (RSV) diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global respiratory syncytial virus (RSV) diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global respiratory syncytial virus (RSV) diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Direct Fluorescent Antibody (DFA) Method
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Rapid Antigen Diagnostic Test (RADTs)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Molecular Diagnostics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Chromatographic Immunoassay
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Diagnostic Imaging
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Gel Microdroplets
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Flow Cytometry
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by End Use

  • 7.1 Hospitals and Clinics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Laboratory
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Becton, Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 bioMerieux SA
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bio-Rad Laboratories Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Coris BioConcept
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 DiaSorin Molecular LLC (DiaSorin Inc)
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 F. Hoffmann-La Roche AG
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 SWOT Analysis
    • 13.3.8 Merck KGaA
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Quest Diagnostics Incorporated
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Quidel Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Thermo Fisher Scientific Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Respiratory Syncytial Virus Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by End Use (in %), 2024
  • Figure 6: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: North America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: North America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: United States: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: United States: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Canada: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Canada: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: China: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: China: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Japan: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Japan: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: India: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: India: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: South Korea: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: South Korea: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Australia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Australia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Indonesia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Indonesia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Europe: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Europe: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Germany: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Germany: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: France: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: France: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: United Kingdom: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: United Kingdom: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Italy: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Italy: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Spain: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Spain: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Russia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Russia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Latin America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Latin America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Brazil: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Brazil: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Mexico: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Mexico: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 77: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Global: Respiratory Syncytial Virus Diagnostics Industry: SWOT Analysis
  • Figure 79: Global: Respiratory Syncytial Virus Diagnostics Industry: Value Chain Analysis
  • Figure 80: Global: Respiratory Syncytial Virus Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Respiratory Syncytial Virus Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 4: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Respiratory Syncytial Virus Diagnostics Market: Competitive Structure
  • Table 6: Global: Respiratory Syncytial Virus Diagnostics Market: Key Players